IRIS
AVERSA, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.864
EU - Europa 6.059
AS - Asia 5.543
SA - Sud America 521
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 22
OC - Oceania 3
Totale 21.075
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.641
CN - Cina 2.769
SG - Singapore 1.943
IE - Irlanda 1.487
SE - Svezia 889
FI - Finlandia 860
IT - Italia 826
DE - Germania 671
TR - Turchia 662
BR - Brasile 475
UA - Ucraina 412
NL - Olanda 385
CA - Canada 198
RU - Federazione Russa 152
FR - Francia 90
GB - Regno Unito 72
AT - Austria 65
BE - Belgio 43
HK - Hong Kong 30
IN - India 29
CI - Costa d'Avorio 28
BD - Bangladesh 24
CZ - Repubblica Ceca 22
EU - Europa 22
AR - Argentina 19
RO - Romania 19
MX - Messico 13
ES - Italia 12
IQ - Iraq 11
PL - Polonia 11
ZA - Sudafrica 11
LT - Lituania 10
EC - Ecuador 8
VE - Venezuela 8
JP - Giappone 7
PK - Pakistan 7
TW - Taiwan 6
CO - Colombia 5
DZ - Algeria 5
IR - Iran 5
NP - Nepal 5
UZ - Uzbekistan 5
ID - Indonesia 4
IL - Israele 4
MA - Marocco 4
PT - Portogallo 4
SI - Slovenia 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
CM - Camerun 3
CR - Costa Rica 3
GR - Grecia 3
JO - Giordania 3
KH - Cambogia 3
PA - Panama 3
RS - Serbia 3
VN - Vietnam 3
AO - Angola 2
AU - Australia 2
BY - Bielorussia 2
DK - Danimarca 2
EG - Egitto 2
GT - Guatemala 2
KE - Kenya 2
KG - Kirghizistan 2
LU - Lussemburgo 2
NG - Nigeria 2
PS - Palestinian Territory 2
PY - Paraguay 2
QA - Qatar 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
SM - San Marino 2
TH - Thailandia 2
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
ML - Mali 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
SN - Senegal 1
Totale 21.075
Salva come PNG Salva come JPEG
Città #
Dublin 1.487
Chandler 1.468
Singapore 1.014
Jacksonville 904
Beijing 786
Izmir 622
Ashburn 566
Nanjing 478
Santa Clara 456
Boardman 415
Dearborn 382
Princeton 352
San Mateo 330
Parma 299
Ann Arbor 236
Wilmington 235
Toronto 170
New York 156
Helsinki 154
Shenyang 153
Kunming 144
Nanchang 141
Shanghai 135
Moscow 134
The Dalles 132
Hebei 115
Council Bluffs 110
Jinan 97
Des Moines 92
Hefei 80
Jiaxing 79
Tianjin 78
Changsha 74
Düsseldorf 59
Vienna 53
Guangzhou 46
Norwalk 46
Milan 40
Los Angeles 37
Seattle 37
Brussels 36
Bologna 33
Hangzhou 32
Kocaeli 29
São Paulo 29
Zhengzhou 29
Abidjan 28
Woodbridge 28
Marseille 27
Chengdu 26
Rome 26
Falls Church 24
Frankfurt am Main 24
Bremen 23
Hong Kong 23
Munich 22
Mestre 21
Fremont 20
Haikou 19
Belo Horizonte 18
San Francisco 18
Dallas 16
Brno 15
Focsani 15
Wuhan 14
Borås 13
Houston 13
Ningbo 13
Frankfurt Am Main 12
Fuzhou 12
Nuremberg 12
Ottawa 12
Chicago 11
Chongqing 11
Grafing 11
Redmond 11
Rio de Janeiro 11
Taizhou 11
Carpi 10
London 10
Modena 10
Pune 10
Radomsko 10
Brasília 9
Redwood City 9
Rockville 9
Guarulhos 8
Porto Alegre 8
West Jordan 8
Changchun 7
Edinburgh 7
Goiânia 7
Lanzhou 7
Osasco 7
Palermo 7
Rio Saliceto 7
San Antonio 7
Taiyuan 7
Xian 7
Boston 6
Totale 13.317
Salva come PNG Salva come JPEG
Nome #
Sindrome preleucemica 144
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 140
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 129
The Proteasome and Myeloma-Associated Bone Disease 128
The -2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity 128
Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20 122
Neurofibromatosis type I and multiple myeloma coexistence: A possible link? 122
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 121
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 118
Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors 116
The -2518 A/G single nucleotide polymorphism of MCP-1 in myelofibrosis: functional characterization on ex-vivo patient cells. 114
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 110
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 109
Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells 106
Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation 105
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 104
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma 104
Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients 103
The osteoblastic niche in the context of multiple myeloma 100
''Designed'' grafts for HLA-haploidentical stem cell transplantation 98
A Rare Case of Systemic AL Amyloidosis with Muscle Involvement: A Misleading Diagnosis 97
Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. 95
Addition of Bortezomib to High Dose Melphalan As Conditioning Regimen for Autologous Stem Cell Transplantation Improves the Response Rate in Newly Diagnosed Multiple Myeloma Patients 95
Primary Prophylaxis of Invasive Fungal Diseases in Allogeneic Stem Cell Transplantation: Revised Recommendations from a Consensus Process by Gruppo Italiano Trapianto Midollo Osseo (GITMO) 95
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 95
Bone Marrow Remodelling and Topographic Redistribution of CD34 Positive Progenitors Characterize the Progression of Myelodysplastic Syndromes and Their Evolution to AML 94
Serie granulocitaria 93
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 93
Hypoxia-Inducible Factor (HIF)-1 alpha Inhibitionin Myeloma Cells Significantly Increases the Anti-Myeloma Effect of Lenalidomide in Vivo 93
GOOD IMMUNOLOGICAL RECONSTITUTION IN ADULTS WITH ACUTE LEUKEMIA AFTER.LFA-BETA TCR/CD19+DEPLETED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) 92
Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression 90
The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells 90
PROTEIN KINASE Ce EXPRESSION IN PRIMARY MYELOFIBROSIS PLATELETS CORRELATES WITH CARDIOVASCULAR EVENTS 89
A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation. 88
EXPRESSION OF CD38 AND ECTOENZYMES OF THE ADENOSINERGIC PATHWAYS IN MYELOMA BONE NICHE: A RATIONAL BASIS FOR THE USE OF DARATUMUMAB TO TARGET OSTEOCLAST FORMATION IN MULTIPLE MYELOMA 88
TLR3 essentially promotes protective class I-restricted memory CD8⁺ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 87
Microbiota control of a tryptophan–AhR pathway in disease tolerance to fungi 87
ERK1/2 is the signaling pathway primarily activated in myeloid neoplasms carrying t(8;9)/PCM1-JAK2 fusion. A two cases report. 87
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory properties 87
The haploidentical option for high-risk haematological malignancies. 86
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 86
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia. 85
Bone marrow CD14+ cells show different transcriptional profiles in Multiple Myeloma (MM) as compared to smoldering MM and MGUS: overexpression of IL21R and its involvement in osteoclastogenesis 85
PCM1-JAK2 Fusion Product Selectively Activates MAP-Kinase Pathway and Fails to Phosphorylate JAK2 and STAT5: Implications for Therapeutic Strategies. 84
Bortezomib improves bone integrity in multiple myeloma patients by blocking osteocyte death and autophagy 84
Platelet expression of PKCepsilon oncoprotein in myelofibrosis is associated with disease severity and thrombotic risk 84
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo 84
T cell depleted haploidentical transplantation: positive selection. 83
Haploidentical stem cell transplantation after negative depletion of T cells expressing the alfabeta chain of the T-cell receptor (TRC) for adults with haematological malignamcies 83
The anti-myeloma effect of Lenalidomide is increased by hypoxia-inducible factor (HIF)-1a inhibition in multiple myeloma cells both in vitro and in vivo 83
T Cell Responses in Fungal Infections 82
Acquisition of Ig isotype diversity after bone marrow transplantation in adults. A recapitulation of normal B cell ontogeny. 82
Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. 82
Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma 82
Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide 82
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients. 82
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 82
Amiloidosi 81
[Evaluation of the immunological status of patients with Hodgkin's disease] 81
Protein Kinase C Epsilon Inhibition Restores In-Vitro Megakaryocyte Differentiation Of Primary Myelofibrosis Hematopoietic Progenitors 80
Acute lymphoblastic leukaemia in Noonan syndrome. 80
Expression Profile of CD38 and Related Ectoenzymes in Myeloma Bone Niche: A Rational Basis for the Use of Daratumumab to Inhibit Osteoclast Formation and Activity 80
Epidemiology of Fungal Infections In Hematological Sem Cells Transplanted Patients: SEIFEM 2004 Study 79
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 79
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation 78
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 78
[Sequential polychemotherapeutic treatment of inoperable bronchogenic carcinoma] 78
Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture 78
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 78
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 78
Non-B, non-T acute lymphoblastic leukaemia terminating in malignant histiocytosis: a new case and a review of the literature. 76
Etiology of febrile episodes in patients with acute myeloid leukemia: results from the Hema e-Chart Registry 76
T cell depleted HLA-identical bone marrow transplants 76
Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses 76
Provision of antifungal immunity and concomitant alloantigen tolerization by conditioned dendritic cells in experimental hematopoietic transplantation. 76
Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. 76
Mieloma multioplo ed altre discrasie linfoplasmacellulari 75
Allogeneic transplants of rhG-CSF-mobilized peripheral blood stem cells (PBSC) from normal donors. GITMO. Gruppo Italiano Trapianto di Midollo Osseo. 75
A prospective survey of febrile events in hematological malignancies 75
Trascriptome Analysis of Bone Marrow CD14+ Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance 75
Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients 75
Allogeneic Hematopoietic stem cell transplantation and natural killer cell alloreactivity, 74
The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38 74
Hypoxia-inducible factor (HIF)-1 is a therapeutic target in myeloma-induced angiogenesis and bone destruction in vitro and in vivo 74
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. 73
Therapeutic Strategy for Elderly Patients with ACUTE Myeloid Leukemia (AML) Carrying the DNMT3A Mutation 73
Allogeneic stem cell transplantation compared with chemotherapy for poor-risk Hodgkin lymphoma. 72
Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation. 72
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 72
Bone marrow monocyte-/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma 72
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? 72
Lenalidomide Increases Human Dendritic Cell Maturation in Multiple Myeloma Modulating Both Monocyte Differentiation and Mesenchymal Stromal Cell Inhibitory Properties through Ikaros and Casein Kinase 1 Degradation, Respectively 72
Lung damage following bone marrow transplantation after hyperfractionated total body irradiation. 71
Germline PTPN11 mutation affecting exon 8 in a case of syndromic juvenile myelomonocytic leukemia 71
Human thrombopoiesis depends on PKCdelta/PKCepsilon functional couple 71
Epidemiology Of Fungal Infections In Hematological Stem Cells Transplantated Patients: SEIFEM-2004 Study ( Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne) 70
Hypoxia-Inducible Factor (HIF)-1a Is A Therapeutic Target in Myeloma-Induced Angiogenesis and Bone Destruction in Vivo 70
The role of total body irradiation in the conditioning of patients receiving haploidentical stem cell transplantation. 69
Is histiocytic reticulosis an infectious disease? 69
A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils. 69
Totale 8.776
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.821
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.821
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020310 0 0 0 0 0 0 0 0 0 0 83 227
2020/20211.388 19 206 39 31 271 25 27 19 438 46 244 23
2021/20221.512 19 15 17 64 45 28 170 257 62 197 85 553
2022/20235.299 688 350 244 381 463 586 60 352 1.913 35 165 62
2023/20241.800 128 230 53 60 155 515 68 116 25 68 144 238
2024/20254.610 62 398 520 413 640 424 182 367 838 627 139 0
Totale 21.379